SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-018528
Filing Date
2019-05-10
Accepted
2019-05-10 16:05:20
Documents
3
Period of Report
2019-06-25
Effectiveness Date
2019-05-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A mnlo-def14a_20190625.htm DEF 14A 894352
2 GRAPHIC geziwrvijpoe000002.jpg GRAPHIC 40194
3 GRAPHIC geziwrvijpoe000001.jpg GRAPHIC 88350
  Complete submission text file 0001564590-19-018528.txt   1072875
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38356 | Film No.: 19814855
SIC: 2834 Pharmaceutical Preparations